Databricks Healthcare Denmark

Novo Nordisk

Data Lake / Data Warehouse Modernization · Enterprise Knowledge Search

Novo Nordisk needed a better way to support clinical trial data democratization and generative AI for faster drug development because clinical data lived across fragmented systems, which slowed collaboration, limited secondary research, and delayed AI-driven trial optimization.

$14M in operational efficiency gains
$157M+ in net new value
20% of the team uses clinical data

Reported impact

Business outcome

Novo Nordisk improved clinical trial data democratization and generative AI for faster drug development with measurable results including 20% of the team uses clinical data, $157M+ in net new value, and $14M in operational efficiency gains, while giving teams a faster path from governed data to production decisions.

  • Productivity Improvement
  • Scalability
  • Speed to Market

Solution

Novo Nordisk uses Databricks Data + AI Platform to support clinical trial data democratization and generative AI for faster drug development. The implementation replaced a legacy state where clinical data lived across fragmented systems, which slowed collaboration, limited secondary research, and delayed AI-driven trial optimization. Clinical trial data and patient demographics move through Spark Declarative Pipelines and land in shared lakehouse datasets, giving teams one trusted data foundation. Unity Catalog governs access, lineage, and compliance across sensitive datasets. Databricks SQL, Model Serving, and Genie operationalize models, agents, and analytics that deliver trial design insights and cohort selection guidance.

Data flow

Clinical trial data and patient demographics land on a shared platform, pipeline services clean and standardize them, governance controls enforce trusted access, and AI, model-serving, and analytics services deliver trial design insights and cohort selection guidance.

Solution architecture

7 components · 4 layers
  1. Ingest
    • Spark Declarative Pipelines Spark Declarative Pipelines standardizes clinical trial data and patient demographics into production-grade tables and features.
  2. Compute
    • Databricks Data + AI Platform Databricks Data + AI Platform unifies engineering, analytics, governance, and AI workloads for clinical trial data democratization and generative AI for faster drug development.
  3. Serving
    • Databricks SQL Databricks SQL serves curated dashboards and ad hoc analysis to trial design insights and cohort selection guidance.
    • Model Serving Model Serving exposes real-time predictions and AI outputs to trial design insights and cohort selection guidance.
    • Genie Genie gives business users natural-language access to governed data for faster decisions around clinical trial data democratization and generative AI for faster drug development.
    • Agent Bricks Agent Bricks packages domain-specific agents that automate parts of clinical trial data democratization and generative AI for faster drug development.
  4. Governance
    • Unity Catalog Unity Catalog applies centralized access controls, lineage, and auditability across sensitive datasets.

Architecture clues

  • $157M+ in net new value
  • 20% of the team uses clinical data
  • Automated ingestion and transformation pipelines keep source data synchronized for downstream analytics and AI.
  • Centralized governance, lineage, and access controls are enforced through Unity Catalog.
  • Operational AI workflows are deployed directly beside governed data and analytics assets.

Evidence from the source

Patients are waiting — how do we go faster?
There’s recognition from senior leadership that good quality data enables better, faster decisions,
This is our top strategic play for how we run clinical development. It’s all hands on deck, including upskilling and growing our AI acumen.
collaboration and back-and-forth exchanges between scientists and medical experts lead to deeper insights.
Transparency Evidence & methodology 100/100 reference value · 89% confidence · 1 source

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value100/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    3 metrics describe measurable impact.
  • Deployment scale10/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence89%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability21/25
    10 of 12 key fields link to a named source.
  • Direct evidence20/20
    4 direct source quotes retained.
  • Date provenance10/10
    The publication date comes from the source page or publisher.
  • Source transparency8/10
    1 source reference document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. Databricks

    Novo Nordisk customer story

    First-party
    https://www.databricks.com/customers/novo-nordisk
    Source type
    Vendor-published customer story
    Published
    Dec 23, 2025
    Supports
    • Customer
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes
    • Publication date

Date evidence

  • Published on source page Dec 23, 2025 · Databricks · First-party
    Open date source
Not separately sourced Industry, Region, Company size. Treat these normalized attributes as lower-confidence until a dedicated source is added.

Related

Similar use cases

See all like this
Databricks Jul 8, 2026 Eurowings Travel and Hospitality Germany Before unifying its data strategy, Eurowings faced significant challenges with siloed data across disparate systems. Technical barriers in vector storage also slowed development, as the team had to manually manage… By implementing semantic search powered by Databricks AI Search and Model Serving, Eurowings achieved a 109%… Data Lake / Data Warehouse ModernizationEnterprise Knowledge Search Agent Bricks · Databricks AI Search · MLflow PwC Jun 5, 2026 CareQuest Institute for Oral Health Healthcare United States CareQuest needed to turn fragmented oral, medical, and social datasets into a secure self-service platform so researchers, policymakers, and internal teams could get timely insights without overwhelming a small central… 10X increase in the research output with only incremental increases in operating cost Data Lake / Data Warehouse ModernizationEnterprise Knowledge Search AI Data Explorer · AI Research Explorer · Health Data Exchange Databricks Feb 16, 2026 Coop Retail Switzerland Coop is a retailer with a unique mission: as a cooperative owned by over 4 million members, its goal isn't just profit, but feeding value back to its owners while prioritizing sustainability. To remain competitive… 30% Retention rate among internal users interacting with AskCap Data Lake / Data Warehouse ModernizationEnterprise Knowledge Search Databricks Data + AI Platform · Delta Lake · Genie